Almost half of weight-loss drug users modify doses, finds survey Results from a survey conducted by LloydsPharmacy Online Doctor also showed that more than one-quarter of respondents said they had knowingly bought weight-loss injections from unlicensed sellers.…
NHS England recommends extension of drug to treat non-metastatic prostate cancer A new NHS clinical commissioning policy has given permission for abiraterone acetate to be prescribed off-label to men with high-risk, hormone sensitive, non-metastatic cancer.…
Abatacept could delay rheumatoid arthritis for high-risk patients Researchers found that abatacept was more effective in delaying the progression of rheumatoid arthritis in patients with high levels of anti-citrullinated protein antibody.…
Type 1 diabetes mellitus and disordered eating An overview of the risks of type 1 diabetes mellitus and disordered eating — or ‘T1DE’, with management and communication considerations for healthcare professionals.…
NICE recommends treatment that could help 30,000 people with COPD Guidance says dupilumab can be offered as an add-on maintenance treatment for adults with uncontrolled COPD.…
Weight-loss drugs among £45m of illegally traded medicines seized in 2025 Medicines and Healthcare products Regulatory Agency figures show that more than 5,000 glucagon-like peptide-1 products were seized in 2025.…
Two-prescriber sign-off no longer required for isotretinoin The Medicines and Healthcare products Regulatory Agency said that scrapping the two-prescriber requirement will address delays in access to acne treatment for patients aged under 18 years old.…
Everything you need to know about PrEP provision in community pharmacy Provision of pre-exposure prophylaxis is increasing across the UK and it has been shown to be highly effective. But why has there been so little progress on the long called-for expansion to provide the drugs via community pharmacy?…
Health news round-up: vaccinations off-site, child health and medicines shortages A weekly summary of important developments in health news that you may have missed.…
NICE approves twice-yearly infusion that ‘significantly outperforms’ usual treatments for severe lupus Guidance says obinutuzumab, taken with daily immunosuppressant tablet mycophenolate mofetil, could benefit around 12,000 people in England.…
